EW
Edwards Lifesciences·NYSE
--
--(--)
--
--(--)
8.79 / 10
Outperform
Analyst consensus is strongly bullish: 40% Strong Buy, 40% Buy, 20% Neutral, with a weighted rating of 9.61. Fund‑flow score is 7.97, showing positive inflows across all investor sizes. Sentiment score 8.79 reinforces a positive market view.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
40%
Buy
40%
Hold
0%
Sell
0%
Strong Sell
0%
Adam MaederBuy
Date2026-02-11
InstitutionPiper Sandler
Times predicted6
Historical Win Rate66.7%
David RomanStrong Buy
Larry BiegelsenBuy
Marie Yoko ThibaultStrong Buy
Richard NewitterNeutral
Is money flowing into or out of EW?
- EW holds a Bullish analyst rating, with 40% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.79/10 (Outperform).
